España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Olema Pharmaceuticals
OLMA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.10
0.31
5.35%
At close: -
$6.25
0.15
2.46%
After Hours: Dec 20, 5:43 PM EDT
Get Report
Comment
Olema Pharmaceuticals (OLMA) Forecast
News
Earnings
Olema Pharmaceuticals (OLMA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Olema Pharmaceuticals (NASDAQ:OLMA) Stock
Olema Pharmaceuticals Stock (NASDAQ: OLMA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Top 3 Health Care Stocks That May Explode In Q4
Avi Kapoor
Thursday, December 12, 2024
HC Wainwright & Co. Reiterates Buy on Olema P...
Benzinga Newsdesk
Wednesday, December 11, 2024
HC Wainwright & Co. Reiterates Buy on Olema P...
Benzinga Newsdesk
Tuesday, December 10, 2024
Olema Pharmaceuticals Announced Updated Resul...
Benzinga Newsdesk
Monday, December 09, 2024
Olema Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Olema Says FDA Cleared IND Application For OP...
Benzinga Newsdesk
Monday, December 02, 2024
Olema Pharmaceutical shares are trading highe...
Benzinga Newsdesk
Olema Pharmaceuticals Announced A New Clinica...
Benzinga Newsdesk
Wednesday, November 13, 2024
HC Wainwright & Co. Reiterates Buy on Olema P...
Benzinga Newsdesk
Tuesday, November 12, 2024
Olema Pharmaceuticals Q3 EPS $(0.60) Misses $...
Benzinga Newsdesk
Thursday, October 24, 2024
HC Wainwright & Co. Reiterates Buy on Olema P...
Benzinga Newsdesk
Wednesday, October 23, 2024
Olema Oncology Highlights Presentation Of Pre...
Benzinga Newsdesk
Friday, October 18, 2024
Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, October 09, 2024
Olema Pharmaceuticals Will Be Presenting Mult...
Benzinga Newsdesk
Thursday, August 08, 2024
JP Morgan Maintains Overweight on Olema Pharm...
Benzinga Newsdesk
Wednesday, August 07, 2024
HC Wainwright & Co. Reiterates Buy on Olema P...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on Olema Ph...
Benzinga Newsdesk
Tuesday, August 06, 2024
Olema Pharmaceuticals Q2 EPS $(0.54) Beats $(...
Benzinga Newsdesk
Tuesday, June 04, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Olema P...
Benzinga Newsdesk
Monday, June 03, 2024
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Olema P...
Benzinga Newsdesk
Olema Oncology Announces Interim Results From...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Maintains Buy on Olema Ph...
Benzinga Newsdesk
Wednesday, May 08, 2024
Olema Pharmaceuticals Q1 EPS $(0.56) Misses $...
Benzinga Newsdesk
Olema Pharmaceuticals Announced That It Will ...
Benzinga Newsdesk
Friday, May 03, 2024
Olema Pharmaceuticals Option Alert: Oct 18 $1...
Charles Gross
Tuesday, April 02, 2024
Goldman Sachs Initiates Coverage On Olema Pha...
Benzinga Newsdesk
Tuesday, March 12, 2024
Oppenheimer Reiterates Outperform on Olema Ph...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Olema Ph...
Benzinga Newsdesk
Monday, March 11, 2024
Olema Pharmaceuticals Q4 EPS $(0.49) Misses $(0.48) Estimate
Happy Mohamed
Thursday, February 01, 2024
Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, January 31, 2024
Olema Pharmaceuticals Filed Prospectus Related To Resale Of Up To 13.2M Shares Of Common Stock Held By Selling Stockholders
Charles Gross
Tuesday, January 30, 2024
Citigroup Initiates Coverage On Olema Pharmac...
Benzinga Newsdesk
Monday, January 08, 2024
Olema Oncology Nominates OP-3136 As A Develop...
Benzinga Newsdesk
Tuesday, December 19, 2023
$6.9M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
Monday, December 11, 2023
Insiders Buying Walt Disney And 3 Other Stocks
Avi Kapoor
Tuesday, December 05, 2023
Olema Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
Olema Oncology Announces Palazestrant Demonst...
Benzinga Newsdesk
Tuesday, November 28, 2023
Olema Oncology To Present New Palazestrant Cl...
Benzinga Newsdesk
Monday, November 27, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Tuesday, November 07, 2023
Olema Pharmaceuticals Q3 EPS $(0.48) Beats $(...
Benzinga Newsdesk
Monday, November 06, 2023
TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday
Lisa Levin
Sunday, October 22, 2023
Olema Oncology Earlier Announced Phase 2 Monotherapy Clinical Study Results For Palazestrant; Showed Results Support Continued Development Of Palazestrant In The OPERA-01 Monotherapy Phase 3 Pivotal Trial
Charles Gross
Tuesday, October 17, 2023
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
Monday, October 16, 2023
Olema Oncology Announces Phase 2 Monotherapy ...
Benzinga Newsdesk
Thursday, October 12, 2023
Olema Pharmaceuticals Announced New Preclinic...
Benzinga Newsdesk
Wednesday, October 11, 2023
Analyst Ratings for Olema Pharmaceuticals
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch